Cellular antioxidant effects of atorvastatin in vitro and in vivo.
about
Statins for women with polycystic ovary syndrome not actively trying to conceiveStatins for women with polycystic ovary syndrome not actively trying to conceiveStatins as regulators of redox state in the vascular endothelium: beyond lipid loweringTargeting NADPH oxidases in vascular pharmacologyNADPH oxidase as a therapeutic target for oxalate induced injury in kidneysPathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stressAtorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic strokeThe effects of high glucose and atorvastatin on endothelial cell matrix production.Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling.Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.Redox control of vascular smooth muscle migration.Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.Novel therapies targeting endometriosisStatins in the treatment of polycystic ovary syndrome.Atorvastatin represses the angiotensin 2-induced oxidative stress and inflammatory response in dendritic cells via the PI3K/Akt/Nrf 2 pathway.Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cellsIn vitro study of lovastatin interactions with amiodarone and with carbon tetrachloride in isolated rat hepatocytesOxidative stress markers are associated to vascular recurrence in non-cardioembolic stroke patients non-treated with statins.Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability.Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis.Tetrahydrobiopterin increases NO-dependent vasodilation in hypercholesterolemic human skin through eNOS-coupling mechanismsEndothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats.Beyond lipid-lowering: effects of statins on endothelial nitric oxide.Oxidative stress markers are associated with persistent atrial fibrillationVascular NAD(P)H oxidases: specific features, expression, and regulation.Association between statin use and uveitis: results from the Pacific Ocular Inflammation studyLipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.Isoprenoid metabolism and the pleiotropic effects of statinsStatin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial.Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidantsAn investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.Redox signalling and cardioprotection: translatability and mechanismNOX1, 2, 4, 5: counting out oxidative stress.Noncholesterol-lowering effects of statins.The many roles of statins in ischemic strokeMicrovascular responsiveness in obesity: implications for therapeutic intervention.Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.
P2860
Q24234599-834551E4-CFD9-46F6-A28D-A5108A7A8955Q24236132-C4BC8702-A730-41A3-9707-90288A8B7252Q26853120-16B20D29-EFCE-47C1-952F-16E2AA8CFDA3Q26863500-71352CAF-2685-4E57-9AD2-9B7B922DE1F1Q27014373-F0C1DF07-5904-4E05-B66A-907CA82100BDQ27015633-27184373-27BF-4119-AC18-84701810E4A1Q28569569-E1A8FC3F-3710-4661-A1D3-17FCA0FF92A5Q31114710-B488674C-81C8-408F-83C2-3664377B15FEQ33555656-601B1C39-6F77-4CAF-A434-EBD8B9905EF6Q33557210-96590981-7AE9-4123-94D2-DDC073FDE71EQ33690103-5EB7EEB1-6429-499E-8EB8-F568D8FE28A9Q33702090-889C70DE-40C1-431F-AB49-440ACC099AA8Q33714186-C5499EE0-E0A9-4AA4-8047-4E9002794BABQ33789151-F0277681-DA0E-44C2-AB23-6253894ACC04Q33930562-59BF7D8B-45A7-4C33-8A4F-9578E5937071Q33947464-F13D4D0E-8F40-49AB-901C-80E336F0FEADQ34086658-079CEA85-0B92-47E4-AC7F-3342F77D92C8Q34098899-26B53D0F-E56B-4E20-89F7-D657FF960271Q34365602-79188943-0963-4763-B834-B25D405BFBD7Q34395409-36F5FFE2-E79E-40ED-8442-6088CEC22326Q34429685-EAFE8465-6091-4AA3-9AB7-C726DA0BAA95Q34454068-460734FF-BDAE-49EF-994E-753755B20873Q34495148-3CDE1D54-5072-4F48-9248-9A564D49FF3DQ35053761-320EC621-598A-4D09-85ED-8300E1D6D695Q35084723-B6252012-7EF8-48C0-BFD4-D80E8CB6E6A6Q35172334-79C81B41-0589-4A3F-9560-C2B63DF0EA36Q35175526-CB0BC5A3-F708-4F68-A19C-F05E03646072Q35181364-CABACA4A-C5E1-40EA-AC7F-6BE8D7BB5DB7Q35187745-7BDCD4B6-7D63-4028-AB6B-4751E6D4E03EQ35197114-E978E4C9-BA13-427A-A44A-8AD3D807F249Q35207701-60880796-2687-4A66-8A0F-6F9B95E1EDAEQ35217467-8A33FF6D-B153-490F-A7E8-8B6D4D605A23Q35278160-2E735EA5-771E-4158-807A-7B57530880CAQ35286322-7E8CE6F8-8402-4F94-9167-3B6C9AA183F3Q35375986-DE04B117-953E-4D97-AE32-7D72B1C41478Q35551180-62D875DD-C38E-4938-B897-2482E894722FQ35595431-B1071655-168F-4E15-9F9E-01CFCA090729Q35859728-4CADFBCC-1900-413F-A041-144E054A1AB1Q35879068-11EBB1F9-AF0A-4E22-86F8-2786089A584CQ35941299-69FDAD0D-DFEC-4D17-A55F-B596214A8FE7
P2860
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@ast
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@en
type
label
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@ast
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@en
prefLabel
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@ast
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@en
P2093
P356
P1476
Cellular antioxidant effects of atorvastatin in vitro and in vivo.
@en
P2093
Anselm T Bäumer
Christian Konkol
Georg Nickenig
Katja Ahlbory
Kirsten Müller
Michael Böhm
Sven Wassmann
Ulrich Laufs
Wolfgang Linz
P304
P356
10.1161/HQ0202.104081
P407
P577
2002-02-01T00:00:00Z